Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Yuhong Zhou is a leading authority in the diagnosis and treatment of pancreatic neuroendocrine neoplasms (pNENs), a rare and highly heterogeneous group of tumors that account for approximately 3% of all pancreatic malignancies. Her most cited work, the 2023 "Chinese Medical Association consensus for standardized diagnosis and treatment of pancreatic neuroendocrine neoplasms," has already garnered 3 citations, reflecting its critical role in establishing clinical guidelines for managing these complex tumors. Dr. Zhou’s research addresses the rising global incidence of pNENs, which originate from pluripotent stem cells with neuroendocrine differentiation, and she has been instrumental in standardizing diagnostic protocols and therapeutic approaches to improve patient outcomes. Her contributions are particularly significant given the rarity and heterogeneity of these tumors, which pose unique challenges for clinicians. By synthesizing evidence-based practices into actionable consensus statements, Dr. Zhou has helped bridge gaps in care and advance the field of neuroendocrine oncology. Her work not only informs clinical decision-making but also sets a foundation for future research into the biology and treatment of pNENs, making her a key figure in this specialized area of pancreatic cancer research.